Sprot- I have a question for you. What other financing options would IPCI have for an unsecured $1.5M loan and what would the interest rate/terms be? Are these other financing options much more attractive in comparison to what we are paying Odidi right now?
I agree delays are partial management and partial FDA. I think there some patent issues too, so it's a lot more complicated than most of us can see from the surface. I can't say for what they did in the last 5 years, but I can see what they did since June of last year. I am still skeptical about investing in heavy, so I have my doubts too, but we also have new expectations based on recent development. You can't denied the value of the MNK deal even if Rexista fails completely.
News 
Market Data 
Discover 
AI
